chitosan and plga microspheres as drug delivery ... - UniCA Eprints

9. References154. Huang Y.Y., Chung T.W., Tzeng T.W. A method using biodegradablepolylactides/polyethylene glycol for drug release with reduced initial burst. Int. J. Pharm. Vol.182, p. 93-100, 1999.155. Jones C.D., Lyon L.A. Synthesis and characterization of multiresponsive core-shell microgels.Macromolecules. Vol. 33, p. 8301-8306, 2000.156. Lee T.H., Wang J., Wang C.H. Double-walled microspheres for the sustained release of ahighly water soluble drug: characterization and irradiation studies. J. Control Release. Vol. 83, p.437-452, 2002.157. Sparnacci K., Laus M., Tondelli L., Magnani L., Bernardi C. Core-shell microspheres bydispersion polymerization as drug delivery systems. Macromol. Chem. Phys. Vol. 203, p. 1364-1369, 2002.158. Zhou S., Deng, X. Yuan, M. Li X. Investigation on preparation and protein release ofbiodegradable polymer microspheres as drug-delivery system. J. Appl. Polym. Sci. vol. 84, p. 778-784, 2002.159. Mathiowitz E., Chickering D.E., Jacob J.S. US Pat. No. 6,197,346, 2001.160. Sakagami M., Kinoshita W., Sakon K., Sato J., Makino Y. Mucoadhesive beclomethasonemicrospheres for powder inhalation: their pharmacokinetics and pharmacodynamics evaluation, J.Control. Release. Vol. 80 p. 207-218, 2002.161. Sakagami M., Sakon K., Kinoshita W., Makino Y. Enhanced pulmonary absorption followingaerosol administration of mucoadhesive powder microspheres, J. Control. Release. Vol. 77, 117-129, 2001.162. Borchard G., Luegen H.L., de Boer A.G., Verhoef J.C., Lehr C.M. Junginger H.E. Thepotential of mucoadhesive polymers in enhancing intestinal peptide drug absorption: III. Effects ofchitosan-glutamate and carbomer on epithelial tight junctions in vitro, J. Control. Release 39(1996) 131– 138.163. Takeuchi H., Matsui Y., Yamamoto H., Kawashima Y., Mucoadhesive properties of carbopolor chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats,J. Control. Release. Vol. 86, p. 235-242, 2003.164. Herrero-Vanrell R., Fernandez-Carballido A., Frutos G., Cadorniga R. Enhancement of themydriatic response to tropicamide by bioadhesive polymers, J. Ocular Pharmacol. Ther. Vol.16, p.419-428, 2000.165. Lim S.T., Forbes B., Martin G.P., Brown M.B. In vivo and in vitro characterization of novelmicroparticulates based on hyaluronan and chitosan hydroglutamate, AAPS PharmSciTech. Vol.2, p. 20, 2001.166. Thompson D.C. Pharmacology of therapeutic aerosols. In Hickey, A.J. (Ed.), PharmaceuticalInhalation Aerosol Technology, Dekker, New York, p. 29-59, 1992.167. Byron P.R., Prediction of drug residence time, in region of the human respiratory tractfollowing aerosol inhalation. J. Pharm. Sci. vol. 75 p. 433-438, 1986.168. Malo J.L., Cartier A., Merland N., Ghezzo It., Burek A., Morris J. and Jennings B.H. Fourtimes-a-daydosing frequency is better than a twice-a-day regimen in subjects requiring a highdoseinhaled steroid, budesonides to control moderate to severe asthma. Am. Rec. Respir. Dis. vol.140, p. 624-628, 1989.169. Patton J.S. and Platz R.M. Pulmonary delivery of peptides and proteins for systemic action.Adv. Drug Del. ReL. vol. 8 p. 179-196, 1992.170. Edwards D.A., Abdelaziz B.J., Langer R. Recent advances in pulmonary drug delivery usinglarge, porous inhaled particles. J Appl Phys. Vol. 85, p. 379-85, 1998.171. Gupta P.K. and Hung C.T., Albumin microspheres: I. Physico-chemical characteristics. J.Microencapsul. vol. 4, p. 427-462, 1989.172. Zeng X.M., Martin G.P. and Marriott C., Tetrandrine delivery to the lung: the optimisation ofthe preparation of albumin microspheres by central composite design. Int. J. Pharm. Vol. 109, p.135-145, 1994.129